Fosfonet

Fosfonet

SCHEMBL9687545

N[C@@H]1CCCC[C@H]1N.O=C([O-])CP(=O)(O)O.O=C([O-])CP(=O)(O)O.[Pt+2]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.42
MMP9 P14780 2/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
MMP1 P03956 1/20 0.42
MMP3 P08254 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42
ANPEP P15144 2/20 0.41
ERAP2 Q6P179 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
THRB P10828 1/20 0.40
GRIN2D O15399 5/20 0.36
GRIN3B O60391 5/20 0.36
GRIN1 Q05586 5/20 0.36
GRIN2A Q12879 5/20 0.36
GRIN2B Q13224 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fosfonet SCHEMBL10627756 0.98 MMP2 (0.41) MMP2MMP9CA12CA1CA2
Malonic Acid SCHEMBL2174031 0.79 CA4 (0.48) MMP2MMP9CA12CA1CA2
Fosfonet SCHEMBL10627749 0.78 MEN1 (0.54) MMP2MMP9CA12CA1CA2
Medronic Acid SCHEMBL10617929 0.76 MMP2 (0.50) MMP2MMP9CA12CA1CA2
SCHEMBL9563827 0.76 THRB (0.50) MMP2MMP9CA12CA1CA2
Medronic Acid SCHEMBL832868 0.76 MMP2 (0.50) MMP2MMP9CA12CA1CA2
Medronic Acid SCHEMBL9838135 0.76 MMP2 (0.50) MMP2MMP9CA12CA1CA2
Oxalic Acid SCHEMBL29422639 0.75 MEN1 (0.56) MMP2MMP9CA12CA1CA2
Oxalic Acid SCHEMBL4859 0.75 MEN1 (0.56) MMP2MMP9CA12CA1CA2
Oxalic Acid SCHEMBL965059 0.75 MEN1 (0.56) MMP2MMP9CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0318464-B1 ANTITUMOR PLATINUM COMPLEXES Bristol-Myers Squibb Company (US) 1992-05-13 EP disclosed
EP-0318464-A2 Antitumor platinum complexes Bristol-Myers Squibb Company (US) 1989-05-31 EP disclosed
EP-0306605-A1 Antitumor platinum complexes Bristol-Myers Squibb Company (US) 1989-03-15 EP disclosed
US-4594418-A A 1,2-cyclohexane platinum complex BRISTOL-MYERS COMPANY (US) 1986-06-10 US disclosed
US-4562275-A ANTICARCINOGENIC AGENTS BRISTOL-MYERS CO. (US) 1985-12-31 US disclosed
EP-0155705-A2 Antitumor platinum complexes Bristol-Myers Squibb Company (US) 1985-09-25 EP disclosed